Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS to Present at Upcoming Investor Conference

MOUNTAIN VIEW, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment...
June 07, 2013 07:00 ET | Source: VIVUS, Inc.

New Article Discusses Treatment Options for Weight Management in People With Type 2 Diabetes

MOUNTAIN VIEW, Calif., June 7, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that a review article has been published online in The Journal of Diabetes and Its Complications...
June 05, 2013 13:45 ET | Source: VIVUS, Inc.

VIVUS Files Definitive Proxy Materials With SEC

Urges Stockholders to Vote FOR the Board's Nominees on GOLD Proxy Card Today Dissidents' Actions Jeopardize VIVUS's Progress at Critical Time MOUNTAIN VIEW, Calif., June 5, 2013 (GLOBE NEWSWIRE)...
June 03, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Scientific Presentations

MOUNTAIN VIEW, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
May 22, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Scientific Presentations

MOUNTAIN VIEW, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
May 16, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes

MOUNTAIN VIEW, Calif., May 16, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today the pricing of its offering of $220 million aggregate principal amount of 4.50% convertible senior...
May 15, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Proposed Offering of Convertible Senior Notes

MOUNTAIN VIEW, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today that it intends to offer, subject to market and other conditions, $200 million aggregate principal...
May 14, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Scientific Presentations

MOUNTAIN VIEW, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
May 13, 2013 07:05 ET | Source: VIVUS, Inc.

VIVUS Mails Letter to Stockholders Providing Business Update

MOUNTAIN VIEW, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today mailed a letter to stockholders providing an update on the Company's recent progress. The full...
May 13, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors

MOUNTAIN VIEW, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the appointment of J. Martin Carroll and Jorge Plutzky, M.D. to its Board of Directors. Mr. Carroll...